A Peer-Reviewed Evidence Bibliography
Migraine Surgery & Peripheral Nerve Decompression
Supporting the safety, efficacy, and clinical validity of surgical nerve decompression for chronic migraine and headache disorders
31 peer-reviewed publications spanning 2005–2025 from Plastic and Reconstructive Surgery, Annals of Surgery, Annals of Plastic Surgery, JAMA Facial Plastic Surgery, Frontiers in Neurology, Cephalalgia, JPRAS Open, European Archives of Oto-Rhino-Laryngology, and other indexed journals.
Introduction: The Case for Surgical Review
More than 39 million Americans suffer from migraine. Despite decades of pharmaceutical innovation, a substantial proportion of patients remain refractory to medical management. For these individuals, a surgical solution has been building a substantial evidence base — yet it remains almost entirely unknown to the general public.
Peripheral nerve decompression surgery — the surgical release of compressed extracranial sensory nerves that trigger migraine — has been studied in multiple randomized controlled trials, five-year longitudinal follow-up studies, and numerous systematic reviews and meta-analyses. Across more than 20 years of peer-reviewed literature, the procedure consistently demonstrates:
- Significant reduction in migraine frequency, duration, and intensity
- Complete elimination of migraine in 30–57% of properly selected patients
- Meaningful improvement (≥50% reduction) in 68–95% of patients
- A favorable safety profile with no major complications across large series
- Durable results sustained at five-year follow-up
The following bibliography organizes the key peer-reviewed evidence by category, with brief annotations contextualizing each study’s significance.
I. Landmark Randomized Controlled Trials
The following RCTs, including a sham-controlled placebo trial, established the scientific foundation for migraine surgery. They are among the most frequently cited works in the field.
1. Guyuron B, Kriegler JS, Davis J, Amini SB. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg. 2005;115(1):1–9. PMID: 15622223. PubMed ↗
Foundational study by the pioneer of migraine surgery demonstrating that surgical decompression of trigger sites significantly reduces migraine frequency, intensity, and duration. Established the multi-trigger-site surgical framework used worldwide.
2. Guyuron B, Reed D, Kriegler JS, Davis J, Pashmini N, Amini S. A placebo-controlled surgical trial of the treatment of migraine headaches. Plast Reconstr Surg. 2009;124(2):461–468. PMID: 18594393. PubMed ↗
Single-blinded, prospective, randomized sham-controlled trial (n=75). Patients receiving actual nerve decompression showed statistically superior improvement vs. sham surgery (83.7% vs. 57.7%, p=0.014) and complete migraine elimination (57.1% vs. 3.8%, p<0.001). The gold-standard RCT in this field.
3. Guyuron B, Kriegler JS, Davis J, Amini SB. Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg. 2011;127(2):603–608.
Five-year longitudinal follow-up of surgical migraine patients (n=79) demonstrating durability of results. Nearly 90% of patients maintained at least partial relief at five years; ~30% achieved complete elimination. Established long-term efficacy.
4. Guyuron B, et al. A Prospective Randomized Outcomes Comparison of Two Temple Migraine Trigger Site Deactivation Techniques. Plast Reconstr Surg. 2015. PMID: 25829156. PubMed ↗
Prospective RCT comparing temporal trigger site decompression vs. neurectomy. Both techniques produced significant, equivalent reduction in migraine frequency and severity, confirming that the surgical principle holds across technique variations.
II. Systematic Reviews & Meta-Analyses
Multiple independent systematic reviews and meta-analyses have synthesized the cumulative evidence, consistently affirming the safety and efficacy of migraine surgery across large pooled populations.
5. ElHawary H, Barone N, Baradaran A, Janis JE. Efficacy and Safety of Migraine Surgery: A Systematic Review and Meta-analysis of Outcomes and Complication Rates. Ann Surg. 2022;275(2):e315–e323. PMID: 35007230. PubMed ↗
Published in Annals of Surgery (impact factor >13), one of medicine’s most prestigious journals. Analyzed 68 studies (38 clinical, 30 anatomical). Found significant overall reduction in migraine intensity, frequency, duration, and MHI. Migraine improvement: 68.3–100%; elimination: 8.3–86.5%. No major complications. Endorses the safety profile of the procedure.
6. Henriques S, Almeida A, Peres H, Costa-Ferreira A. Current Evidence in Migraine Surgery: A Systematic Review. Ann Plast Surg. 2022;89(1):113–120. PMID: 34611094. PubMed ↗
PRISMA-compliant systematic review of 52 studies from four major databases. Significant improvement in 58.3–100% of patients; complete elimination in 8.3–86.8%. No major complications reported. Concludes migraine surgery is effective, safe, and reduces long-term healthcare costs.
7. Vincent AJPE, van Hoogstraten WS, Maassen Van Den Brink A, van Rosmalen J, Bouwen BLJ. Extracranial Trigger Site Surgery for Migraine: A Systematic Review With Meta-Analysis on Elimination of Headache Symptoms. Front Neurol. 2019;10:89. PMC6383414. Full text ↗
Meta-analysis of 14 controlled studies encompassing 847 records. Odds ratio for complete migraine elimination after surgery vs. controls: 21.46. Average headache elimination rate 38% at 6–12 months. Provides the strongest comparative statistical argument for surgical intervention.
8. Ogunlade J, et al. Surgical Management of Migraine Headaches: A Systematic Review and Meta-analysis. 2019. PMID: 30557190. PubMed ↗
Meta-analysis of 616 patients demonstrating significant reduction in migraine frequency, and a 797-patient analysis showing significant reduction in intensity. Provides strong aggregate evidence on the most clinically meaningful outcomes.
9. Evans AG, Hill DS, Grush AE, Downer MA, Ibrahim MM, Assi PE, Joseph JT, Kassis SH. Outcomes of Surgical Treatment of Migraines: A Systematic Review & Meta-Analysis. Global Neurosurgery. 2023. DOI: 10.1177/22925503211036701. Full text ↗
Independent surgical outcomes review. Average MIDAS score reduction from 57 to 20 post-surgery; average migraine intensity reduction from 8.31 to 4.06 on a 10-point scale. Demonstrates dramatic functional improvement in patient quality of life.
10. Afifi AM, et al. Migraine Surgery and Determination of Success over Time by Trigger Site: A Systematic Review of the Literature. 2022. PMID: 36251961. PubMed ↗
Examines outcomes by anatomical trigger site, refining the understanding of which patients benefit most from which procedure. Supports the individualized, anatomy-driven surgical approach.
11. Al-Khatib A, et al. Surgical interventions for intractable migraine: a systematic review and meta-analysis. Int J Surg. 2024. PMC11486983. Full text ↗
The most recent (2024) comprehensive meta-analysis. Synthesizes the evidence for intractable migraine surgery with updated data, confirming continued acceptance of the procedure across the surgical literature.
III. Occipital & Peripheral Nerve Decompression: Clinical Outcomes
These studies examine the specific procedure used for posterior (occipital) migraine and headache, covering the anatomical territory of the greater, lesser, and third occipital nerves.
12. Baldelli I, Mangialardi ML, Salgarello M, Raposio E. Peripheral Occipital Nerve Decompression Surgery in Migraine Headache. Plast Reconstr Surg Glob Open. 2020;8(10):e3019. PMID: 33173659. PubMed ↗
PRISMA systematic review of 1,046 patients across 9 studies specifically examining occipital nerve decompression. Positive response rate (>50% headache reduction) ranged from 80.0% to 94.9%. Demonstrates the strong efficacy of posterior nerve surgery for this anatomical subtype.
13. Alizadeh K, Kreinces JB, Smiley A, Gachabayov M. Clinical Outcome of Nerve Decompression Surgery for Migraine Improves with Nerve Wrap. Plast Reconstr Surg Glob Open. 2021;9(10):e3886. PMID: 34703716. PubMed ↗
Retrospective cohort of 153 patients; 84.3% showed clinical improvement at 1-year follow-up. Identifies acellular dermal matrix nerve wraps as a significant independent predictor of success (OR=10.80). Advances the technical refinement of the procedure.
14. Aydin MA, et al. Single midline incision approach for decompression of greater, lesser and third occipital nerves in migraine surgery. 2022. PMC9204865. Full text ↗
Describes a refined surgical approach treating multiple posterior nerve targets through a single incision, supporting the minimally invasive direction of the field.
15. Decompression of the greater occipital nerve improves outcome in patients with chronic headache and neck pain — a retrospective cohort study. 2021. PMC8357752. Full text ↗
Documents greater occipital nerve (GON) decompression efficacy in patients with comorbid chronic headache and cervicogenic pain — a population broader than classic migraine patients.
16. Refractory occipital neuralgia treatment with nerve decompression surgery: a case series. 2023. PMC10713752. Full text ↗
Demonstrates nerve decompression success in occipital neuralgia refractory to all prior treatments. NRS pain score dropped from 7.9 to 3.7; medication use fell from 3.2 to 1.3 agents per patient. Relevant for the most treatment-resistant patients.
17. Blake P, Nir R-R, Perry CJ, Burstein R. Tracking patients with chronic occipital headache after occipital nerve decompression surgery: A case series. Cephalalgia. 2019. DOI: 10.1177/0333102418801585. Full text ↗
Published in Cephalalgia (the official journal of the International Headache Society). Co-authored by Rami Burstein, a leading headache neuroscientist at Harvard Medical School, lending neurology-community credibility to the surgical approach.
IV. Pathophysiology: The Anatomical Basis for Surgery
These studies address the foundational scientific question: why does nerve decompression work? They establish the causal link between extracranial nerve compression and migraine symptoms.
18. Causal Relation between Nerve Compression and Migraine Symptoms and the Therapeutic Role of Surgical Decompression. 2015. PMC4457258. Full text ↗
Reviews the evidence for anatomical nerve compression as a causal — not merely correlative — mechanism in migraine pathophysiology. Establishes the rationale for treating migraine as an anatomical problem requiring a structural solution, not solely a neurochemical one.
19. Reduction in Chronic Migraine following Occipital Nerve Decompression Surgery: Further Implications for Extracranial Origin of Headache (P2.170). Neurology. 2017;88(16 Supplement).
Published in Neurology (the flagship journal of the American Academy of Neurology). Surgical outcomes data appearing in a neurology journal carries significant weight with non-surgical providers who remain skeptical of claims from plastic surgery publications.
V. Diagnostic Predictors: Identifying the Right Patients
A critical aspect of the safety and efficacy profile of migraine surgery is patient selection. These studies validate the diagnostic tools used to identify surgical candidates.
20. The Positive and Negative Predictive Value of Targeted Diagnostic Botox Injection in Nerve Decompression Migraine Surgery. 2023. PMID: 37285182. PubMed ↗
Validates the use of targeted Botox injections as a diagnostic and prognostic tool. Patients with a positive Botox response show ~90% improvement in MHI vs. ~49% in negative responders. Notably, over half of Botox non-responders still improve with surgery. Refines the patient selection algorithm.
21. Targeted Peripheral Nerve-directed Onabotulinumtoxin A Injection for Effective Long-term Therapy for Migraine Headache. 2017. PMC5404453. Full text ↗
Supports targeted (not diffuse) nerve-directed Botox injections as both effective long-term therapy and a diagnostic test. Validates the TIM (Targeted Injection Mapping) approach as a bridge between conservative and surgical management.
VI. The State of the Field: Access, Delay, and Undertreatment
These publications document the gap between the available evidence and actual patient access — a problem greater public awareness could help address.
22. Treatment Delay in Patients Undergoing Headache Surgery (Nerve Decompression Surgery). JPRAS Open. 2023;38:226–236. PMC10624566. Full text ↗
Directly quantifies the treatment gap: the median time from onset of headache symptoms to surgery was 20 years. Despite proven efficacy, headache surgery has not been incorporated into standard headache management algorithms. This is the human cost of the awareness problem — two decades of suffering before patients find a surgical solution.
23. Guyuron B. The Evolution of Migraine Surgery: Two Decades of Continual Research. My Current Thoughts. Plast Reconstr Surg. 2021. PMID: 34019513. PubMed ↗
A perspective from the pioneer of the field summarizing 20 years of evidence. Addresses criticisms, outlines what is now established, and identifies directions for future research. Essential context for understanding the scientific maturity of the field.
24. Introduction to the Virtual Special Issue: Migraine Surgery in JPRAS Open. JPRAS Open. 2024. PMC10827495. Full text ↗
A dedicated Virtual Special Issue in JPRAS Open (Journal of Plastic, Reconstructive & Aesthetic Surgery) consolidating the most significant migraine surgery publications — a marker of the field’s growing institutional recognition.
25. Integrative Migraine Therapy: From Current Concepts to Future Directions — A Plastic Surgeon’s Perspective. 2025. PMC12843410. Full text ↗
The most recent (2025) comprehensive review situating nerve decompression surgery within the full spectrum of migraine treatments. Calls for integration of surgical options into multidisciplinary headache management — a position gaining traction across the field.
VII. Anterior Nerve Decompression: Supraorbital & Supratrochlear Nerves
Frontal migraine — pain at the forehead and brow — is driven by compression of the supraorbital and supratrochlear nerves where they pass through or adjacent to bony foramina and notches, and through the corrugator supercilii and procerus muscles. The studies below document outcomes and anatomy specific to anterior trigger site surgery.
26. Chepla KJ, Oh E, Guyuron B. Clinical outcomes following supraorbital foraminotomy for treatment of frontal migraine headache. Plast Reconstr Surg. 2012;129(4):656e–662e. PMID: 22456379. PubMed ↗
Compared glabellar myectomy alone vs. myectomy with supraorbital foraminotomy in 86 patients. The addition of foraminotomy produced significantly better outcomes across all measures: MHI score (26.5 vs. 11.1), migraine frequency (7.8 vs. 4.1/month), and persistent forehead pain (48.8% vs. 25.6%). Established foraminotomy as a critical component of frontal trigger site surgery.
27. Liu MT, Chim H, Guyuron B. Outcome comparison of endoscopic and transpalpebral decompression for treatment of frontal migraine headaches. Plast Reconstr Surg. 2012;129(5):1113–1119. PMID: 22544095. PubMed ↗
The largest comparative study of surgical approaches for frontal migraine (n=253). Endoscopic supraorbital/supratrochlear nerve decompression achieved an 89% success rate (at least 50% reduction in frequency, duration, or intensity) vs. 79% for the transpalpebral approach (p<0.05). Endoscopic decompression is now the preferred technique.
28. Ortiz R, Gfrerer L, Hansdorfer MA, Nealon KP, Lans J, Austen WG Jr. Migraine Surgery at the Frontal Trigger Site: An Analysis of Intraoperative Anatomy. Plast Reconstr Surg. 2020;145(2):523–530. PMID: 31985652. PubMed ↗
From Harvard / Massachusetts General Hospital. Analyzed 118 surgical sites in 61 patients and found macroscopic nerve compression in 74% of cases, with causes including tight foramina, notch bands, and nerve crowding. Confirms the anatomical basis for surgery at the frontal trigger site and explains why Botox injections into this region provide diagnostic and therapeutic benefit.
29. Raposio E, Simonacci F. Frontal Trigger Site Deactivation for Migraine Surgical Therapy. Plast Reconstr Surg Glob Open. 2020;8(4):e2813. PMID: 32440458. PubMed ↗
Prospective series of 70 frontal decompression surgeries over 8 years with 24-month mean follow-up. Reported a 94% positive response rate: 32% achieved complete relief and 62% achieved significant improvement. Only 6% had no change. Directly addresses the frontal headache patient population.
30. Filipovic B, de Ru JA, Hakim S, van de Langenberg R, Borggreven PA, Lohuis PJFM. Treatment of Frontal Secondary Headache Attributed to Supratrochlear and Supraorbital Nerve Entrapment With Oral Medication or Botulinum Toxin Type A vs Endoscopic Decompression Surgery. JAMA Facial Plast Surg. 2018;20(5):394–400. PMID: 29801115. PubMed ↗
Published in JAMA Facial Plastic Surgery. Head-to-head controlled comparison: endoscopic decompression surgery was superior to both oral medication and Botox injection for frontal headache attributed to supraorbital/supratrochlear nerve entrapment. The clinical takeaway: surgery outperformed the treatments most patients have already tried.
31. Filipovic B, de Ru JA, van de Langenberg R, et al. Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review. Eur Arch Otorhinolaryngol. 2017;274:2093–2106. PMID: 28124109. PubMed ↗
Comprehensive review published in European Archives of Oto-Rhino-Laryngology, a peer-reviewed ENT journal. Summarizes the evidence for endoscopic decompression of the supraorbital and supratrochlear nerves, noting long-lasting successful outcomes with minor adverse effects. Demonstrates cross-specialty recognition of this surgical approach beyond the plastic surgery literature.
Summary: What the Evidence Shows
The 31 publications cited in this bibliography span two decades of peer-reviewed research published in leading plastic surgery, general surgery, neurology, otolaryngology, and pain medicine journals. Together they establish:
- Efficacy: 68–100% of properly selected patients experience meaningful improvement; 30–57% achieve complete migraine elimination.
- Durability: Results sustained at five-year follow-up.
- Safety: No major complications across large multi-center series.
- Scientific rigor: Evidence includes placebo-controlled RCTs, five-year follow-up, and multiple independent meta-analyses.
- A critical access gap: a median 20 years between symptom onset and surgery, driven by public and provider unawareness.
The science is established. Public awareness is the missing piece — and journalism is one of the most effective tools for closing that gap.
